GlassScriptPhysician profile
David Charchian
NPI 1114902822
$3,798.14
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,048 · 2020: $700 · 2021: $812 · 2022: $239.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $764.96 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $632.79 | 2019-2022 | |
| Astellas Pharma US INC | $350.75 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $302.34 | 2019-2022 | |
| Glaxosmithkline, LLC. | $269.66 | 2019-2020 | |
| Ironwood Pharmaceuticals, INC | $223.28 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $191.80 | 2019 | |
| Novo Nordisk INC | $174.77 | 2019-2020 | |
| Allergan, INC. | $149.29 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $144.19 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $123.58 | 2019 | |
| Lilly USA, LLC | $96.65 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $65.15 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $55.61 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $50.88 | 2020-2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $44.62 | 2019 | |
| Redhill Biopharma INC. | $34.83 | 2020-2021 | |
| Amgen INC. | $27.66 | 2021 | |
| Pfizer INC. | $25.68 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $21.07 | 2021 | |
| Eisai INC. | $19.68 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.12 | 2019 | |
| Vertiflex, INC. | $12.78 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Charchian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.